phrma

“Since 2020, changes in how the program operates have created significant challenges for providers across Illinois. Federally qualified health centers in Illinois have lost at least $60 million because of restrictions,” Moeller said. #centerssquare #pharma

Launched in 1992, the 340B program requires drug manufacturers that participate in Medicaid to provide outpatient medications at substantial discounts to providers that serve large numbers of uninsured, underinsured and Medicaid patients. #drugpricing #lawmakers #capitolnewsillinois